Home » Newsletters » BioWorld Science

BioWorld Science

July 14, 2003

View Archived Issues

Adefovir dipivoxil in chronic hepatitis B

Beneficial effects described for bortezomib in patients with relapsed, refractory myeloma

Potential new molecularly targeted therapies for diseases related to activated PDGFR-alpha

Reduced toxicity and improved antitumor effects for IL-2 when coadministered with M-40403

MDX-010 combined with tumor vaccines in metastatic melanoma

Nonuterotrophic and nonmammotrophic ERbeta ligands presented by Wyeth

Novel PTP1B inhibitors prepared and tested by JT researchers

Pharmasset patent covers new anti-HIV and anti-HBV agents

Series of potassium channel modulators and their use reported by Wyeth

Pfizer researchers present new antidiarrheal agents in recent patent

New telomerase inhibitors under study at Kyowa Hakko

New antiproliferative agents in Sankyo development pipeline

Cytotoxic macrolactones discovered at GBF assumed to act by inhibiting V-ATPase

JNJ-10258859: a novel PDE5 inhibitor with potential in erectile dysfunction

Erectile responses to DA-8159 in rabbit models

Promising activity reported for Nipent combination therapy in NHL

Parenteral anti-MRSA cephalosporin antibiotic characterized by Takeda

Enrollment completed for phase I/II study of 131I-TM-601 in glioma

Theratechnologies completes patient enrollment in phase II ThGRF study

China approves Sumitomo's antianxiety drug Sediel

Daiichi Radioisotope files for marketing approval of Dopascan Injection in Japan

Ivax initiates phase II trial of talampanel for brain cancer

Schering announces positive phase III results for MS-325

BMS presents second-generation farnesyltransferase inhibitors at AACR meeting

Optimization of CDK-2 inhibitor series as orally active antitumor agents

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...